Alvine Initiates Recruitment for Phase 2a Clinical Trial of ALV003 Intended for the Treatment of Celiac Disease.

SAN CARLOS, Calif., August 25, 2009 – Alvine Pharmaceuticals, Inc. announces that patient enrollment has begun for Phase 2a of

read more